Table 3.
Association of Donor and Recipient BKPyV Serotype With Development of Viremia and BKPyVAN in Recipients During Follow-up
| All Recipients, No. (%) (n = 386) | Viremic Recipients, No. (%) (n = 103) | |||||
|---|---|---|---|---|---|---|
| BKPyV Serotype | No BKPyV Viremia (n = 283) | BKPyV Viremia (n = 103) | P Valuea | No BKPyVAN (n = 92) |
BKPyVAN (n = 11) |
P Valuea |
| Donors | ||||||
| I | 238 (72) | 93 (28) | .42 | 82 (88) | 11 (12) | .68 |
| II | 37 (82) | 8 (18) | 8 (100) | 0 (0) | ||
| III | 3 (100) | 0 (0) | 0 (0) | 0 (0) | ||
| IV | 5 (71) | 2 (29) | 2 (100) | 0 (0) | ||
| Recipients | >.99 | |||||
| I | 243 (73) | 88 (27) | .88 | 78 (89) | 10 (11) | |
| II | 27 (71) | 11 (29) | 10 (91) | 1 (9) | ||
| III | 9 (82) | 2 (18) | 2 (100) | 0 (0) | ||
| IV | 4 (67) | 2 (33) | 2 (100) | 0 (0) | ||
| Donor-recipient pair | ||||||
| Matched | 205 (72) | 79 (28) | .40 | 71 (90) | 8 (10) | .72 |
| Mismatched | 78 (76) | 24 (24) | 21 (88) | 3 (13) | ||
Abbreviations: BKPyV, BK polyomavirus; BKPyVAN, BKPyV-associated nephropathy.
a P values were calculated using χ2 or Fisher exact tests, with results considered statistically significant at P < .05.